Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel

被引:35
作者
Patael-Karasik, Y
Daniely, M
Gotlieb, WH
Ben-Baruch, G
Schiby, J
Barakai, G
Goldman, B
Aviram, A
Friedman, E [1 ]
机构
[1] Chaim Sheba Med Ctr, Susanne Levy Gertner Oncogenet Lab, Inst Genet, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Inst Human Genet, IL-52621 Tel Hashomer, Israel
[3] Chaim Sheba Med Ctr, Gynecol Oncol Unit, IL-52621 Tel Hashomer, Israel
[4] Chaim Sheba Med Ctr, Dept Pathol, IL-52621 Tel Hashomer, Israel
关键词
D O I
10.1016/S0165-4608(00)00224-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To gain an understanding of the molecular mechanisms of or arian cancer, we analyzed 16 ovarian tumors from Jewish Israeli patients by comparative genomic hybridization: 12 invasive epithelial tumors (including three BRCA1 and one BRCA2 mutation carriers), 2 primary peritoneal carcinomatosis, I pseudomyxoma peritoneii tumor, and 1 sertoli cell tumor. We similarly analyzed 1 normal ovary from a BRCA1 mutation carrier, and 3 metastases. The most common abnormalities in epithelial tumors rr-ere amplification of 8q22.1-ter (8/12, 66.6%), 1q22-32.1 (5/22, 41.6%), 3q, 10p (4/12, 33.3% for each), and deletions of 9q (5/22, 41.6%) and 16q21-24 (4/12, 33.3%). All 3 BRCA1 mutation carriers and 2 of 8 sporadic cases displayed 9q deletion, and 2 of 3 BRCA1 mutation carriers, but none of the sporadic cases, had deletion of chromosome 19. The range of genetic changes in primary peritoneal tumors and epithelial of ovarian cancers nas similar, though the mean number of alterations in the former rr as less (3.5/tumor versus 8/tumor). Our preliminary results may indicate that inherited predisposition to ovarian cancer possibly entails preferential somatic deletions of chromosomes 9 and 19. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 40 条
[1]  
Abeliovich D, 1997, AM J HUM GENET, V60, P505
[2]  
Arnold N, 1996, GENE CHROMOSOME CANC, V16, P46, DOI 10.1002/(SICI)1098-2264(199605)16:1<46::AID-GCC7>3.0.CO
[3]  
2-3
[4]   C-MYC AMPLIFICATION IN OVARIAN-CANCER [J].
BAKER, VV ;
BORST, MP ;
DIXON, D ;
HATCH, KD ;
SHINGLETON, HM ;
MILLER, D .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :340-342
[5]  
Berchuck A, 1998, CLIN CANCER RES, V4, P2433
[6]  
BERCHUCK A, 1990, CANCER RES, V50, P4087
[7]  
BRYNDORF T, 1995, AM J HUM GENET, V57, P1211
[8]  
COREY SJ, 1994, LEUKEMIA, V8, P1914
[9]   Karyotypic analysis of 32 malignant epithelial ovarian tumors [J].
Deger, RB ;
Faruqi, SA ;
Noumoff, JS .
CANCER GENETICS AND CYTOGENETICS, 1997, 96 (02) :166-173
[10]  
DOLCETTI R, 1991, EUR ARCH OTO-RHINO-L, V248, P279